Abate Kristin — SEC Form 4 filings
SEC reporting owner CIK 2045943. 12 Form 4 filings on record with FilingPulse; latest filed 2026-09-02.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2025-03-04 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 10 legs across 10 filings — 2,152 shares, $14,785 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: sale of 559 shares @ $9.41 ($5,260) in Karyopharm Therapeutics Inc., filed 2026-03-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | 12 | — | 10 legs · 2,152 sh · $14,785 | 6 |
Form 4 filings — Abate Kristin
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-02 | 4 | Karyopharm Therapeutics Inc. (KPTI) | Sale (S): 19 @ $2.02 | EDGAR |
| 2026-05-15 | 4 | Karyopharm Therapeutics Inc. (KPTI) | Grant/award (A): 121 @ $0 · Sale (S): 53 @ $9.50 | EDGAR |
| 2026-03-03 | 4 | Karyopharm Therapeutics Inc. (KPTI) | Sale (S): 559 @ $9.41 | EDGAR |
| 2026-01-29 | 4 | Karyopharm Therapeutics Inc. (KPTI) | Grant/award (A): 92 @ $0 · Sale (S): 50 @ $7.03 | EDGAR |
| 2026-01-22 | 4 | Karyopharm Therapeutics Inc. (KPTI) | Sale (S): 265 @ $5.96 | EDGAR |
| 2025-10-16 | 4 | Karyopharm Therapeutics Inc. (KPTI) | Grant/award (A): 12,799 @ $0 | EDGAR |
| 2025-10-03 | 4 | Karyopharm Therapeutics Inc. (KPTI) | Sale (S): 362 @ $6.30 | EDGAR |
| 2025-09-16 | 4 | Karyopharm Therapeutics Inc. (KPTI) | Grant/award (A): 46 @ $0 · Sale (S): 23 @ $6.43 | EDGAR |
| 2025-09-04 | 4 | Karyopharm Therapeutics Inc. (KPTI) | Sale (S): 12 @ $6.78 | EDGAR |
| 2025-07-23 | 4 | Karyopharm Therapeutics Inc. (KPTI) | Sale (S): 238 @ $4 | EDGAR |
| 2025-03-06 | 4 | Karyopharm Therapeutics Inc. (KPTI) | Sale (S): 571 @ $6.29 | EDGAR |
| 2025-03-04 | 4 | Karyopharm Therapeutics Inc. (KPTI) | Grant/award (A): 933 @ $0 · Grant/award (A): 1,866 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2045943 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →